木瓜直播

How GLP-1 drugs are reshaping medicine

Federal government would pick up about three-fourths of the cost for Medicaid coverage

News and commentary from the endocrinology world

A conversation with bariatric surgeon Christine J. Ren-Fielding, MD

In WeightWatchers study, 45% decreased their alcohol use after initiating a weight-loss drug

"Weight is multifactorial," researcher noted

"It's discouraging," says one patient

First positive phase III study for a GLP-1 agonist in chronic liver disease

Balancing aspiration risk with the consequences of medication discontinuation

Addition of GLP-1 drugs led to an even greater reduction

News and commentary from the endocrinology world

Most are eligible for weight management indication

SUMMIT trial able to show clinical benefit beyond quality-of-life improvement

Real-world data suggested semaglutide, liraglutide reduced AUD-related hospitalizations